Senior Investor Relations Manager
Who We Are:
Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. (*in collaboration with AbbVie)
About the Role:
Neurocrine Biosciences is seeking a highly motivated and strategic Senior Investor Relations Manager to support the execution of a best-in-class IR program. This role serves as a key partner to the Vice President of Investor Relations and collaborates closely with senior leadership, Finance, Legal, Commercial, and Corporate Communications to effectively communicate the company’s strategy, financial performance, and pipeline progress to the investment community.The Senior Manager operates with a high degree of autonomy and is responsible for leading key components of the IR strategy and driving execution of complex, high-impact initiatives. This individual will serve as a recognized functional expert in Investor Relations, shaping investor messaging, influencing engagement strategy, driving alignment across senior stakeholders and recommending enhancements to IR processes, tools and practices.
_
Your Contributions (include, but are not limited to):
Partner with the VP of Investor Relations to recommend, develop and execute IR strategy and priorities
Translate business performance, pipeline updates, and corporate strategy into clear, compelling investor narratives
Lead preparation of quarterly earnings materials, including press releases, scripts, presentations, and Q&A
Develop investor presentations, executive briefing materials, and content for investor events
Serve as a primary point of contact for select investors and sell-side analysts
Support and lead execution of investor events, including earnings calls, investor days, conferences, and non-deal roadshows
Ensure consistency, clarity, and strategic alignment across all external communications and disclosures
Partner cross-functionally with Finance, Legal, Commercial, R&D, and Corporate Communications
Influence senior stakeholders to align on messaging, positioning, and disclosure strategy
Analyze investor sentiment, market dynamics, peer performance, competitive landscape and emerging industry trends to inform IR strategy and messaging
Provide actionable insights and recommendations to the VP and senior leadership
Anticipate emerging trends, risks, and opportunities; proactively refine messaging accordingly
Drive continuous improvement of IR processes, tools, and engagement tracking
Ensure compliance with all regulatory and disclosure requirements
Requirements:
Bachelor’s degree in Finance, Business, Life Sciences, or related field with 8+ years of relevant experience OR
Master’s degree with 6+ years of experience OR
Advanced degree (PhD/JD) with 4+ years of experience
Relevant experience in investor relations, equity research, investment banking, corporate communications, or corporate finance strongly preferred
Biotech, pharmaceutical, or healthcare industry experience highly preferred
Strong understanding of capital markets, equity valuation methodologies, institutional investor behavior, and sell-side research processes
Demonstrated experience developing and delivering investor-facing communications, including earnings materials, investor presentations, executive briefing documents, and Q&A preparation
Knowledge of SEC disclosure requirements, Regulation FD, and public company investor relations practices
Experience analyzing financial results, market trends, investor sentiment, and competitive dynamics to develop actionable business insights
Ability to interpret and communicate complex clinical, scientific, and regulatory developments into clear investment messaging
Strategic thinker with strong business and financial acumen
Excellent written and verbal communication skills
High level of professionalism and executive presence
Strong analytical and problem-solving capabilities
Collaborative, cross-functional mindset with the ability to influence without authority
Proactive, detail-oriented, and able to manage multiple priorities in a fast-paced environment
High integrity and sound judgment
#LI-TM1
Neurocrine Biosciences is an EEO/Disability/Vets employer.
We are committed to building a workplace of belonging, respect, and empowerment, and we recognize there are a variety of ways to meet our requirements. We are looking for the best candidate for the job and encourage you to apply even if your experience or qualifications don’t line up to exactly what we have outlined in the job description.
_
The annual base salary we reasonably expect to pay is $148,500.00-$203,000.00. Individual pay decisions depend on various factors, such as primary work location, complexity and responsibility of role, job duties/requirements, and relevant experience and skills. In addition, this position offers an annual bonus with a target of 30% of the earned base salary and eligibility to participate in our equity based long term incentive program. Benefits offered include a retirement savings plan (with company match), paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage in accordance with the terms and conditions of the applicable plans.Investment Banking pay context
Based on 552 disclosed Investment Banking salaries on RoleSuite, the role pays a median of $123K/year, with most offers between $90K and $166K (10th–90th percentile: $72K–$234K).
This posting lists $149K–$203K, above the $123K market median.
See the full Investment Banking salary breakdown →